Jan 13, 2012 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/1e9aa0/competitor_analysi) has announced the addition of the "Competitor Analysis: HIV Small Molecule Therapeutics" report to their ...
Domain Info:
PREMIER THERAPEUTICS blog focused on THERAPEUTICS tips and PRE
Trending on Social Networks
VisitorDay Search
Sorry, no results found in 
knowledge-sharing database for these terms.
knowledge-sharing database for these terms.
Business Listing
"Advertise your site here by describing your Expertise and how you can benefit Visitor Day Community."
Trending on the Internet
Jan 16, 2012 (M2 EQUITYBITES via COMTEX) -- Aperture Health Inc (OTC APRE.PK) announced on Sunday that it has completed the acquisition of Triad Therapeutics Inc, a homecare infusion therapy and nursing provider in New Jersey serving the tri-state area ...
Echo Therapeutics to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference
PHILADELPHIA, Jan. 11, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. ECTE, a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System ...
(RTTNews) - Canadian biopharmaceutical company Lorus Therapeutics Inc. (LOR.TO: News ,LRUSF.PK: News ) Friday said its loss for the second quarter widened on higher expenses. Meanwhile, loss per share narrowed, owing to higher share count. The company ...
- Cheap Hotels
Find chippest hotels in a history of finding chip hotels
www.ChipestShithall.edu - Cheap Hotels
Find chippest hotels in a history of finding chip hotels
www.ChipestShithall.edu
Jan 13, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Halozyme Therapeutics (HALO) on October 18th, 2011 at $7.28. In approximately 3 months, Halozyme Therapeutics has returned 34.68% as of today's recent price of $9.81 ...
Akebia Therapeutics Inc., a pharmaceutical company focused on treatments for anemia, has drawn down a $4.1 million tranche of its previously announced Series B financing. Investors included Novartis Bioventures, Venture Investors, Triathlon Medical ...
- Cheap Hotels
Find chippest hotels in a history of finding chip hotels
www.ChipestShithall.edu - Cheap Hotels
Find chippest hotels in a history of finding chip hotels
www.ChipestShithall.edu
Research and Markets: Generalized Anxiety Disorders (GAD) Therapeutics - Current Treatment Options are Moderately Successful in Meeting Market Demand Business Wire DUBLIN -- January 16, 2012 Research and Markets(http://www.researchandmarkets.com ...
Research and Markets(http://www.researchandmarkets.com/research/db02ae/venous_thromboembo) has announced the addition of GlobalData 's new report "Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to ...
CAMBRIDGE, Mass. & DANVILLE, Pa., Jan 17, 2012 (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. (otc/bb:NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and Geisinger Health System today ...
FAIRFIELD, N.J., Jan. 15, 2012 /PRNewswire/ -- Aperture Health, Inc. (OTC APRE.PK) announced that it has completed the acquisition of Triad Therapeutics, Inc., ("Triad") a homecare infusion therapy and nursing provider in New Jersey serving ...
